vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Zeta Global Holdings Corp. (ZETA). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $394.6M, roughly 1.2× Zeta Global Holdings Corp.). Zeta Global Holdings Corp. runs the higher net margin — 1.7% vs -10.1%, a 11.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 25.4%). Zeta Global Holdings Corp. produced more free cash flow last quarter ($60.9M vs $-69.0M). Over the past eight quarters, Zeta Global Holdings Corp.'s revenue compounded faster (42.3% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Zeta Global Holdings Corp. is an American marketing technology company which was founded in 2007. Zeta offers companies a suite of multichannel marketing tools focused on creating, maintaining, and monetizing customer relationships. The company went public on the New York Stock Exchange on June 10, 2021, at a US$1.7 billion valuation.

CLOV vs ZETA — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.2× larger
CLOV
$487.7M
$394.6M
ZETA
Growing faster (revenue YoY)
CLOV
CLOV
+19.3% gap
CLOV
44.7%
25.4%
ZETA
Higher net margin
ZETA
ZETA
11.8% more per $
ZETA
1.7%
-10.1%
CLOV
More free cash flow
ZETA
ZETA
$129.9M more FCF
ZETA
$60.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
ZETA
ZETA
Annualised
ZETA
42.3%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
ZETA
ZETA
Revenue
$487.7M
$394.6M
Net Profit
$-49.3M
$6.5M
Gross Margin
59.5%
Operating Margin
-10.1%
4.5%
Net Margin
-10.1%
1.7%
Revenue YoY
44.7%
25.4%
Net Profit YoY
-123.2%
-57.1%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ZETA
ZETA
Q4 25
$487.7M
$394.6M
Q3 25
$496.6M
$337.2M
Q2 25
$477.6M
$308.4M
Q1 25
$462.3M
$264.4M
Q4 24
$337.0M
$314.7M
Q3 24
$331.0M
$268.3M
Q2 24
$356.3M
$227.8M
Q1 24
$346.9M
$194.9M
Net Profit
CLOV
CLOV
ZETA
ZETA
Q4 25
$-49.3M
$6.5M
Q3 25
$-24.4M
$-3.6M
Q2 25
$-10.6M
$-12.8M
Q1 25
$-1.3M
$-21.6M
Q4 24
$-22.1M
$15.2M
Q3 24
$-9.2M
$-17.4M
Q2 24
$7.4M
$-28.1M
Q1 24
$-19.2M
$-39.6M
Gross Margin
CLOV
CLOV
ZETA
ZETA
Q4 25
59.5%
Q3 25
60.5%
Q2 25
62.1%
Q1 25
60.9%
Q4 24
60.0%
Q3 24
24.5%
60.6%
Q2 24
30.3%
60.0%
Q1 24
23.6%
60.6%
Operating Margin
CLOV
CLOV
ZETA
ZETA
Q4 25
-10.1%
4.5%
Q3 25
-4.9%
2.6%
Q2 25
-2.2%
-1.7%
Q1 25
-0.3%
-6.1%
Q4 24
-6.4%
2.2%
Q3 24
-2.7%
-4.6%
Q2 24
2.0%
-11.7%
Q1 24
-6.5%
-18.4%
Net Margin
CLOV
CLOV
ZETA
ZETA
Q4 25
-10.1%
1.7%
Q3 25
-4.9%
-1.1%
Q2 25
-2.2%
-4.2%
Q1 25
-0.3%
-8.2%
Q4 24
-6.6%
4.8%
Q3 24
-2.8%
-6.5%
Q2 24
2.1%
-12.3%
Q1 24
-5.5%
-20.3%
EPS (diluted)
CLOV
CLOV
ZETA
ZETA
Q4 25
$0.04
Q3 25
$-0.02
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$0.10
Q3 24
$-0.09
Q2 24
$-0.16
Q1 24
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ZETA
ZETA
Cash + ST InvestmentsLiquidity on hand
$78.3M
$319.8M
Total DebtLower is stronger
$197.1M
Stockholders' EquityBook value
$308.7M
$804.6M
Total Assets
$541.0M
$1.5B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ZETA
ZETA
Q4 25
$78.3M
$319.8M
Q3 25
$385.2M
Q2 25
$365.3M
Q1 25
$364.4M
Q4 24
$194.5M
$366.2M
Q3 24
$288.0M
$418.5M
Q2 24
$254.8M
$154.7M
Q1 24
$208.3M
$141.6M
Total Debt
CLOV
CLOV
ZETA
ZETA
Q4 25
$197.1M
Q3 25
$196.9M
Q2 25
$196.7M
Q1 25
$196.5M
Q4 24
$196.3M
Q3 24
$196.1M
Q2 24
$184.4M
Q1 24
$184.2M
Stockholders' Equity
CLOV
CLOV
ZETA
ZETA
Q4 25
$308.7M
$804.6M
Q3 25
$340.9M
$689.2M
Q2 25
$344.2M
$673.3M
Q1 25
$336.1M
$676.6M
Q4 24
$341.1M
$676.8M
Q3 24
$342.2M
$474.9M
Q2 24
$324.9M
$217.0M
Q1 24
$292.5M
$191.6M
Total Assets
CLOV
CLOV
ZETA
ZETA
Q4 25
$541.0M
$1.5B
Q3 25
$559.7M
$1.2B
Q2 25
$575.0M
$1.1B
Q1 25
$583.7M
$1.1B
Q4 24
$580.7M
$1.1B
Q3 24
$653.0M
$869.1M
Q2 24
$674.2M
$583.9M
Q1 24
$671.8M
$550.3M
Debt / Equity
CLOV
CLOV
ZETA
ZETA
Q4 25
0.24×
Q3 25
0.29×
Q2 25
0.29×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.41×
Q2 24
0.85×
Q1 24
0.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ZETA
ZETA
Operating Cash FlowLast quarter
$-66.9M
$64.1M
Free Cash FlowOCF − Capex
$-69.0M
$60.9M
FCF MarginFCF / Revenue
-14.1%
15.4%
Capex IntensityCapex / Revenue
0.4%
0.8%
Cash ConversionOCF / Net Profit
9.81×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$185.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ZETA
ZETA
Q4 25
$-66.9M
$64.1M
Q3 25
$12.1M
$57.9M
Q2 25
$5.4M
$42.0M
Q1 25
$-16.3M
$34.8M
Q4 24
$34.8M
$43.7M
Q3 24
$50.0M
$34.4M
Q2 24
$44.8M
$31.1M
Q1 24
$25.9M
$24.7M
Free Cash Flow
CLOV
CLOV
ZETA
ZETA
Q4 25
$-69.0M
$60.9M
Q3 25
$11.4M
$52.4M
Q2 25
$4.8M
$39.7M
Q1 25
$-16.5M
$32.1M
Q4 24
$33.3M
$35.4M
Q3 24
$49.6M
$29.5M
Q2 24
$44.4M
$24.4M
Q1 24
$25.5M
$18.9M
FCF Margin
CLOV
CLOV
ZETA
ZETA
Q4 25
-14.1%
15.4%
Q3 25
2.3%
15.6%
Q2 25
1.0%
12.9%
Q1 25
-3.6%
12.1%
Q4 24
9.9%
11.3%
Q3 24
15.0%
11.0%
Q2 24
12.5%
10.7%
Q1 24
7.3%
9.7%
Capex Intensity
CLOV
CLOV
ZETA
ZETA
Q4 25
0.4%
0.8%
Q3 25
0.1%
1.6%
Q2 25
0.1%
0.8%
Q1 25
0.0%
1.0%
Q4 24
0.5%
2.6%
Q3 24
0.1%
1.8%
Q2 24
0.1%
3.0%
Q1 24
0.1%
3.0%
Cash Conversion
CLOV
CLOV
ZETA
ZETA
Q4 25
9.81×
Q3 25
Q2 25
Q1 25
Q4 24
2.87×
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons